SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 229 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,890 | -53.9% | 58,170 | 0.0% | 0.00% | – |
| Q2 2023 | $75,621 | -13.2% | 58,170 | +17.5% | 0.00% | – |
| Q1 2023 | $87,152 | -43.9% | 49,518 | 0.0% | 0.00% | – |
| Q4 2022 | $155,487 | -35.9% | 49,518 | 0.0% | 0.00% | – |
| Q3 2022 | $242,638 | +25.7% | 49,518 | +6.4% | 0.00% | – |
| Q2 2022 | $193,000 | -28.8% | 46,558 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $271,000 | -22.3% | 46,558 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $349,000 | -18.6% | 46,558 | -2.2% | 0.00% | 0.0% |
| Q3 2021 | $429,000 | -24.7% | 47,624 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $570,000 | -9.8% | 47,624 | -5.6% | 0.00% | 0.0% |
| Q1 2021 | $632,000 | -19.5% | 50,434 | +0.3% | 0.00% | -50.0% |
| Q4 2020 | $785,000 | +106.6% | 50,291 | +25.1% | 0.00% | +100.0% |
| Q3 2020 | $380,000 | +5.6% | 40,213 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $360,000 | -1.9% | 40,213 | -30.2% | 0.00% | 0.0% |
| Q1 2020 | $367,000 | -21.2% | 57,577 | +3.3% | 0.00% | 0.0% |
| Q4 2019 | $466,000 | +16.8% | 55,723 | +26.4% | 0.00% | 0.0% |
| Q3 2019 | $399,000 | -16.0% | 44,098 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $475,000 | +18.8% | 44,098 | +5.1% | 0.00% | 0.0% |
| Q1 2019 | $400,000 | -17.0% | 41,959 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $482,000 | -28.6% | 41,959 | +5.4% | 0.00% | 0.0% |
| Q3 2018 | $675,000 | +19.5% | 39,807 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $565,000 | -19.7% | 39,807 | +7.5% | 0.00% | -50.0% |
| Q1 2018 | $704,000 | +12.8% | 37,034 | -2.6% | 0.00% | +100.0% |
| Q4 2017 | $624,000 | +9.5% | 38,027 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $570,000 | +91.3% | 38,027 | +12.5% | 0.00% | 0.0% |
| Q2 2017 | $298,000 | +87.4% | 33,809 | +10.7% | 0.00% | – |
| Q1 2017 | $159,000 | +71.0% | 30,539 | 0.0% | 0.00% | – |
| Q4 2016 | $93,000 | -98.5% | 30,539 | -97.7% | 0.00% | -100.0% |
| Q3 2016 | $6,275,000 | -8.3% | 1,355,208 | +14.7% | 0.01% | -29.4% |
| Q2 2016 | $6,843,000 | +0.7% | 1,181,883 | +5.2% | 0.02% | 0.0% |
| Q1 2016 | $6,797,000 | -32.9% | 1,123,458 | +1.3% | 0.02% | -32.0% |
| Q4 2015 | $10,126,000 | +35.6% | 1,109,012 | -16.2% | 0.02% | +31.6% |
| Q3 2015 | $7,466,000 | -30.7% | 1,323,662 | +36.4% | 0.02% | -24.0% |
| Q2 2015 | $10,766,000 | -6.4% | 970,753 | +32.4% | 0.02% | -3.8% |
| Q1 2015 | $11,496,000 | +27.7% | 733,174 | +23.9% | 0.03% | +30.0% |
| Q4 2014 | $9,003,000 | +1704.2% | 591,913 | +1178.1% | 0.02% | +1900.0% |
| Q3 2014 | $499,000 | -29.4% | 46,313 | 0.0% | 0.00% | -50.0% |
| Q2 2014 | $707,000 | -15.5% | 46,313 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $837,000 | +30.2% | 46,313 | 0.0% | 0.00% | +100.0% |
| Q4 2013 | $643,000 | +32.6% | 46,313 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $485,000 | +34.0% | 46,313 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $362,000 | – | 46,313 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,000,000 | $66,540,000 | 6.69% |
| FIC CAPITAL INC | 787,529 | $8,734,000 | 3.47% |
| RA Capital Management | 1,220,209 | $13,532,000 | 1.36% |
| PRINCETON CAPITAL MANAGEMENT INC | 114,120 | $1,266,000 | 0.67% |
| Perceptive Advisors | 800,000 | $8,872,000 | 0.53% |
| Cormorant Asset Management, LP | 361,000 | $4,003,000 | 0.53% |
| Highlander Capital Management, LLC | 43,500 | $482,000 | 0.43% |
| APEX CAPITAL, LLC | 439,900 | $4,878,000 | 0.42% |
| WASATCH ADVISORS LP | 3,091,386 | $34,283,000 | 0.37% |
| Baker Brothers Advisors | 3,230,932 | $35,831,000 | 0.31% |